NCCN’s Global programs seek to further advance the organization’s mission to improve and facilitate quality, effective, equitable, and accessible cancer care so all patients can live better lives. NCCN is devoted to defining and advancing high-quality,
high-value, patient-centered cancer care globally.
The influence of NCCN Content continues to gather momentum throughout all regions of the world, with more than 13 million copies of the NCCN Guidelines® downloaded worldwide. Nearly half of the more than 1.2 million registered users of the NCCN Guidelines on NCCN.org report that they live outside the United States.
In order to increase the global access to high quality, high value cancer care, NCCN has developed strategic global initiatives to ensure awareness, accessibility, and relevancy of NCCN resources.
NCCN works to translate the NCCN Guidelines and Guidelines for Patients® into multiple languages and publishes these important resources on NCCN.org as well as within NCCN mobile application for free so that they may be accessed by clinicians around the world.
NCCN collaborates with third party organizations across the globe to present Regional Adaptations of the NCCN Guidelines and associated resources that account for local accessibility, consideration of metabolic differences in populations, and regulatory status of health care technologies used in cancer care in the specified country or region.
The NCCN Framework™ guides evidence-based adaptation to available clinical treatment resources. NCCN Guidelines are used widely around the world, including in a number of low- and middle-resource countries where certain diagnostic tests and/or treatment approaches may be unavailable.
These targeted regional resources are created as part of a collaborative effort to combat the skyrocketing cancer rates and unique care circumstances. They represent both the optimal care that low- and mid-resource countries aspire to provide and pragmatic approaches that provide effective treatment options for resource-constrained settings.